Amwill Health Care Limited has confirmed no deviation or variation in the utilization of IPO proceeds compared to the objectives outlined in its prospectus.

The Audit Committee reviewed and approved the statement on fund utilization for the half-year ending 31st March 2025. This indicates disciplined financial management post-IPO, reassuring shareholders that the capital raised is being used as intended to support the company’s growth plans.